Volume | 701,378 |
|
|||||
News | - | ||||||
Day High | 47.78 | Low High |
|||||
Day Low | 45.825 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Praxis Precision Medicines Inc | PRAX | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
46.01 | 45.825 | 47.78 | 47.46 | 45.48 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
5,370 | 701,378 | $ 46.74 | $ 32,780,984 | - | 12.45 - 67.21 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:37:12 | 1 | $ 46.23 | USD |
Praxis Precision Medicines (PRAX) Options Flow Summary
Praxis Precision Medicines Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
629.09M | 13.24M | - | 2.45M | -123.28M | -9.31 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Praxis Precision Medicines News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PRAX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 42.76 | 47.78 | 41.76 | 45.08 | 179,207 | 4.70 | 10.99% |
1 Month | 55.40 | 56.72 | 39.57 | 45.90 | 263,719 | -7.94 | -14.33% |
3 Months | 57.62 | 67.21 | 39.57 | 52.07 | 264,554 | -10.16 | -17.63% |
6 Months | 17.00 | 67.21 | 14.775 | 46.21 | 200,808 | 30.46 | 179.18% |
1 Year | 14.0415 | 67.21 | 12.45 | 23.54 | 582,681 | 33.42 | 238.00% |
3 Years | 294.00 | 353.40 | 11.85 | 55.01 | 764,450 | -246.54 | -83.86% |
5 Years | 408.15 | 914.2575 | 11.85 | 87.28 | 681,112 | -360.69 | -88.37% |
Praxis Precision Medicines Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others. |